United States

Braveheart Bio, Inc. (BRVE)

Track

Braveheart Bio, Inc. recorded eight insider trading transactions on August 7, 2026, all representing buys. Seven distinct insiders, including the CEO and CFO, acquired shares totaling approximately $69.39 million. These purchases occurred amid a 0.7% stock price change over the last ninety days, with no recent earnings report data available for context.
Ticker: BRVE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Buy 7 Aug 2026
Value US$302,617.83 | Price 53.11 | Shares 78,886 (+2.4%)
Buy 7 Aug 2026
Value US$1,146,243.13 | Price 41.77 | Shares 1,351 (+35.7%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-07 2026-08-07 B Purchase
Forbion Growth Opportunities Fund III Cooperatief U.A.
Large shareholder
78,886 +2.4%
53.11
US$302,618 		78,886 +2.4% 53.11 US$302,618
2026-08-07 2026-08-07 B Purchase
Forbion Growth Opportunities Fund III Cooperatief U.A.
Large shareholder
1,351 +35.7%
41.77
US$1,146,243 		1,351 +35.7% 41.77 US$1,146,243
2026-08-07 2026-08-07 B Purchase
3.3
Rickey James Paul

Chief Financial Officer

Officer
98,326 +8.4%
486.83
US$1,528,826 		98,326 +8.4% 486.83 US$1,528,826
2026-08-07 2026-08-07 B Purchase
2.2
Lubner David Charles
Non-Executive Director
1,000 +inf%
18.00
US$100,000 		1,000 +inf% 18.00 US$100,000
2026-08-07 2026-08-07 B Purchase
Murdoch Travis

CEO and President

Executive Director
1,000 +2.9%
18.00
US$100,000 		1,000 +2.9% 18.00 US$100,000
2026-08-07 2026-08-07 B Purchase
Anderson Michele A.

Chief Development Officer

Officer
1,000 +0.3%
18.00
US$100,000 		1,000 +0.3% 18.00 US$100,000
2026-08-07 2026-08-07 B Purchase
2.9
Viehbacher Christopher
Non-Executive Director
1,000 +15.8%
18.00
US$100,000 		1,000 +15.8% 18.00 US$100,000
2026-08-07 2026-08-07 B Purchase
Malek David I
Non-Executive Director
1,000 +0.8%
18.00
US$100,000 		1,000 +0.8% 18.00 US$100,000
Explore more

More insider trading research around Braveheart Bio, Inc.

More insider trades in United States
Insider trading in North America